Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The 0.5 mg/mL inclusion is well below any clinical toxicity threshold and has no effect on tirzepatide's GIP or GLP-1 receptor binding
Funding This study has been granted funding from the Centre of Excellence Scheme and the University of Bergen (UiB), Norway to the Centre for Intervention Science in Maternal and Child Health (CISMAC
Adverse event Any unwanted medical event during a trial, whether or not it was caused by the compound
Accurate volumes support reliable dosing during repeated injection preparation steps
US$ 27.36
US$ 21.73
US$ 24.33
US$ 28.00
US$ 29.47
